Nevro Eliminates Two-Thirds of Source Data Verification with Medrio ePRO and EDC
Global medical device maker Nevro successfully integrates Medrio EDC and ePRO to transition from paper to digital data collection.
The way you capture study data can make or break your organizational success, so why settle. Medrio’s EDC technology is intuitive, scalable, and proven across more than 8,000 studies to date.
Don’t risk slowing down study progress, or missing a crucial go-to-market window. Choose the EDC that puts you in control, meets the strictest of global data collection regulations, and is purpose-built to assure the integrity, security, and quality of study data.
Medrio is very responsive. The teams are professional, but they still act like a partner, not as a vendor… I don’t even know how big the organization is because I’m lucky enough to get to speak to the same people over and over again.”
Melanie Marshall, Senior Manager of Data Operations, Oncobay
Our quick builds and intuitive user interface introduce new efficiencies without compromising data quality. When your data capture strategy is built on the right technology foundation, anything is possible – including shorter timelines that allow you to scale up with ease.
I’m not a programmer, but after just a couple of hours of training [with Medrio EDC], I was able to start building. I very rarely have problems, even when making mid-study changes, and I think it is user-friendly for the end users as well. Plus, the customer service is top-notch.”
Courtnay Buonomo, Associate Director of Clinical Study Database Design, Heron Therapeutics
We revolutionized the industry in 2015 by balancing sophisticated software with an intuitive, user-friendly interface. But we didn’t stop there – our team progressively advances our EDC software with direct customer input. Medrio delivered more than 70 product enhancements across 14 product releases in 2022, alone.
Shorten onboarding, reduce costs, and minimize delays when you take control of your EDC with an intuitive, point-and-click foundation.
Make data accessible via web on any device, anywhere to approved individuals in real-time and improve decision-making.
Ensure the right data is captured with built-in edit checks and queries. Baked in quality assurance reduces validation costs and on-site monitoring.
Improve visibility across study data by leveraging Medrio’s eClinical suite of eConsent, ePRO, and RTSM to seamlessly feed data into your EDC.
Implement cutting-edge flexibility without complexity at every stage of the development cycle. Through 20 years of continued innovation, our EDC has grown into a solution users can manage independently, so you can reduce costs, cut timelines, and respond quickly to change.
Medrio is an incredibly intuitive system to learn, especially compared to other traditional EDC systems. The workflow for building a clinical database is very efficient, with lots of more advanced features that can be leveraged as needed. Onboarding was smooth and easy, thanks to a series of helpful meetings and active followup by Medrio.”
Associate Director of Data Management, biotech
Global medical device maker Nevro successfully integrates Medrio EDC and ePRO to transition from paper to digital data collection.
RefleXion taps Medrio’s service and expertise to help build and launch the first studies for the breakthrough cancer treatment SCINTIX™ biology-guided radiotherapy.
Rose Research Center Counts on Medrio EDC and ePRO to simplify its transition from paper to digital data collection and increase the workflow efficiency of its tobacco cessation clinical studies.
See participant data as soon as it’s entered, even before an electronic diary is fully complete, for full visibility into compliance trends and adverse events.
Upon consent, participant diaries are automatically delivered through Medrio eConsent.
No matter the study phase or type, deploying the right randomization and trial supply management technology improves efficiency and protects patients.
© Copyright 2023 Medrio, Inc. All rights reserved.
Sign up to have our the latest insights delivered to your inbox.